TABLE 2.
Method | C. auris (No. isolates) | Closely-Related Yeasts (No. isolates) | Other Yeasts (No. isolates) | Clinical specimen (No.) | Sensitivity (%) | Specificity (%) | References |
Mass spectrometry | |||||||
Bruker | 90 | 12 | ND | ND | 100 | 100 | Kathuria et al., 2015 |
Bruker | 82 | 11 | ND | ND | 100 | 100 | Girard et al., 2016 |
Bruker, CMdb database | 33 | 62 | 16 | ND | 100 | 100 | Bao et al., 2018 |
MALDI | 3 | 298 | ND | ND | 100 | 100 | Arastehfar et al., 2019a |
MALDI, PXD016387 database | 300 | 8 | ND | ND | 100 | 100 | Ceballos-Garzon et al., 2020 |
Autof MS 1000 | 2 | 1216 | ND | ND | 100 | 100 | Yi et al., 2021 |
Vitek MS | 2 | 1216 | ND | ND | 100 | 100 | Yi et al., 2021 |
Biotyper | 61 | ND | ND | ND | 75.4–83.6 | ND | Kwon et al., 2019 |
Vitek MS | 61 | ND | ND | ND | 93.4–96.7 | ND | Kwon et al., 2019 |
Differential media | |||||||
CHROMagarTM with Pal’s medium | 15 | 13 | ND | ND | 100 | 100 | Kumar et al., 2017 |
CHROMagarTM Candida Plus | 37 | 58 | ND | swab (23) | 100 | 100 | Mulet Bayona et al., 2020 |
CHROMagarTM Candida Plus | 10 | 52 | ND | ND | ND | 98 | Borman et al., 2021 |
CHROMagarTM Candida Plus | 9 | 35 | ND | ND | 90 | 100 | de Jong et al., 2021 |
Selective media | |||||||
Selective Auris Medium | 133 | 446 | ND | Bactec blood culture broth (40) | 100 | 100 | Das et al., 2021 |
Specific C. auris (SCA) Medium | 7 | 128 | 50 | stool (200) | 100 | 100 | Ibrahim et al., 2021b |